TTop stories Read More Trump set to fire FDA Commissioner Marty Makary after stormy tenureMay 8, 2026 President Trump has reportedly signed off on a plan to dismiss Food and Drug Administration Commissioner Marty Makary.…
TTop stories Read More Intellia Therapeutics moves HAE treatment closer to approvalApril 28, 2026 Intellia Therapeutics said Monday that a single dose of its gene editing treatment dramatically reduced swelling attacks in…
TTop stories Read More Erasca touts strong early results in pancreatic and lung cancer therapy trialApril 28, 2026 Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
TTop stories Read More Eli Lilly’s $3.25B acquisition of Kelonia Therapeutics caps startup’s tortuous rideApril 20, 2026 Eli Lilly is spending $3.25 billion to acquire Kelonia Therapeutics, a small biotech company developing cell therapies for…
TTop stories Read More Revolution Medicines touts success in pancreatic cancer treatmentApril 13, 2026 Metastatic pancreatic cancer patients who received a targeted pill from Revolution Medicines lived nearly twice as long as…
TTop stories Read More Replimune skin cancer drug that became FDA flashpoint is rejected againApril 11, 2026 The Food and Drug Administration on Friday rejected — again — an experimental treatment for advanced skin cancer…
TTop stories Read More 5 lessons from Vinay Prasad’s turbulent tenure at the FDAMarch 9, 2026 Food and Drug Administration official Vinay Prasad self-destructed last week. The FDA announced Friday evening that he would…
TTop stories Read More What the FDA’s Moderna rejection means for every vaccine makerFebruary 13, 2026 The Food and Drug Administration’s refusal to review Moderna’s flu vaccine this month has renewed fears that Trump…
TTop stories Read More Prasad takes a familiar, conservative approach to drug approvalsFebruary 12, 2026 Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
TTop stories Read More Prasad overruled FDA staff to reject Moderna flu vaccine applicationFebruary 11, 2026 WASHINGTON — Top Food and Drug Administration official Vinay Prasad overruled the agency’s reviewers when he refused to accept…
TTop stories Read More FDA refuses to review Moderna’s flu vaccine applicationFebruary 11, 2026 Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her…
HHeadlines Read More Selective depletion of tumor-associated SAMHD1 enhances chemotherapeutic efficacy and antitumor immune responsesDecember 15, 2025 Study approval All experimental animal procedures were performed in compliance with the Chinese. The study was conducted in…